Monte Carlo simulations of absorbed dose in a mouse phantomfrom 18-fluorine compounds
The purpose of this study was to calculate internal absorbed dose distribution in mice from preclinical small animal PET imaging procedures with fluorine-18 labeled compounds ( FDG 18 , FLT 18 , and fluoride ion). The GATE Monte Carlo software and a realistic, voxel-based mouse phantom that included...
Gespeichert in:
Veröffentlicht in: | Medical physics (Lancaster) 2007-02, Vol.34 (3), p.1026-1036 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The purpose of this study was to calculate internal absorbed dose distribution in mice from preclinical small animal PET imaging procedures with fluorine-18 labeled compounds (
FDG
18
,
FLT
18
, and fluoride ion). The GATE Monte Carlo software and a realistic, voxel-based mouse phantom that included a subcutaneous tumor were used to perform simulations. Discretized time-activity curves obtained from dynamic
in vivo
studies with each of the compounds were used to set the activity concentration in the simulations. For
FDG
18
, a realistic range of uptake ratios was considered for the heart and tumor. For each simulated time frame, the biodistribution of the radionuclide in the phantom was considered constant, and a sufficient number of decays were simulated to achieve low statistical uncertainty. Absorbed dose, which was scaled to take into account radioactive decay, integration with time, and changes in biological distribution was reported in mGy per MBq of administered activity for several organs and uptake scenarios. The mean absorbed dose ranged from a few mGy/MBq to hundreds of mGy/MBq. Major organs receive an absorbed dose in a range for which biological effects have been reported. The effects on a given investigation are hard to predict; however, investigators should be aware of potential perturbations especially when the studied organ receives high absorbed dose and when longitudinal imaging protocols are considered. |
---|---|
ISSN: | 0094-2405 2473-4209 |
DOI: | 10.1118/1.2558115 |